Inhalation of glycopyrronium inhibits cigarette smoke-induced acute lung inflammation in a murine model of COPD
Inhalation of glycopyrronium inhibits cigarette smoke-induced acute lung inflammation in a murine model of COPD
复制标题
吸入格隆铵可抑制慢性阻塞性肺病小鼠模型中香烟烟雾引起的急性肺部炎症
DOI:
10.1016/j.intimp.2013.12.021
复制
发表时间:
2014-02-01
影响因子:
5.6
通讯作者:
Xie, Qiang-min
中科院分区:
文献类型:
--
作者:
Shen, Liang-liang;Liu, Ya-nan;Xie, Qiang-min
Glycopyrronium bromide (GB) is a muscarinic receptor antagonist that has been used as a long-acting bronchodilator in chronic obstructive pulmonary disease (COPD) patients. The aim of this study was to investigate the anti-inflammatory activity of inhaled GB in a cigarette smoke-induced acute lung inflammation mouse model. We found that aerosol pre-treatment with GB suppresses the accumulation of neutrophils and macrophages in the bronchoalveolar lavage fluid (BALF) in cigarette smoke (CS)-exposed mice. GB at doses of 300 and 600 mu g/ml significantly inhibited the CS-induced increases in the mRNA and protein expression levels of interleukin (IL)-1 beta tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1 and transforming growth factor (TGF)-beta 1 in lung tissues and the BALF. Moreover, GB at a dose of 600 mu g/ml significantly inhibited the CS-induced changes in glutathione (GSH) and myeloperoxidase (MPO) activities in the BALF, decreased the CS-induced expression of matrix metalloproteinases (MMP)-9, and increased the CS-induced expression of tissue inhibitor of metalloproteinases (TIMP)-1, as determined through the immunohistochemical staining of lung tissue. Our results demonstrate the beneficial effects of inhaled GB on the inflammatory reaction in COPD. (C) 2013 Published by Elsevier B.V.